Who
Angie You
Director
Company insider
Files Form 4 as: Director, Attovia Therapeutics; Director, Oric Pharmaceuticals; Director, RayzeBio; Chief Bus. & Strat. Officer, Sierra Oncology.
In numbers
- Trades disclosed
- 18
- Buys
- 3
- Sells
- 0
- Bought
- $306K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 8 Mar 2016
- Last trade
- 4 Aug 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Aug 2026filed 6 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 23 Jun 2025filed 23 Jun 2025 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $13K1,403 at $9.43 | filing |
| 20 Jun 2025filed 23 Jun 2025 | ORIC Oric PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $250K26,597 at $9.39 | filing |
| 2 Jan 2025filed 6 Jan 2025 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 12 Jun 2024filed 14 Jun 2024 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,600 at $0.00 | filing |
| 26 Feb 2024filed 27 Feb 2024 | RayzeBiooption or derivative | SEC FORM 4 Code D | —73,731 | filing |
| 26 Feb 2024filed 27 Feb 2024 | RayzeBiooption or derivative | SEC FORM 4 Code D | —40,848 | filing |
| 14 Jun 2023filed 15 Jun 2023 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,500 at $0.00 | filing |
| 17 Jun 2022filed 17 Jun 2022 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,158 at $0.00 | filing |
| 9 Nov 2021filed 10 Nov 2021 | ORIC Oric Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,250 at $0.00 | filing |
| 6 Mar 2018filed 7 Mar 2018 | Sierra Oncologyoption or derivative | SEC FORM 4 Code A | —180,360 at $0.00 | filing |
| 8 Mar 2017filed 9 Mar 2017 | Sierra Oncology | SEC FORM 4 Bought | $43K30,000 at $1.43 | filing |
| 6 Mar 2017filed 8 Mar 2017 | Sierra Oncologyoption or derivative | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 30 Sep 2016filed 4 Oct 2016 | ProNAi Therapeuticsoption or derivative | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 8 Mar 2016filed 10 Mar 2016 | ProNAi Therapeuticsoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.